Articles

At a session PATH co-hosted at the African Union Summit, Africa leaders highlighted slow progress toward continental immunization goals and called for accelerated action.

Most of the world’s vaccine manufacturing capacity is in high-income countries, creating barriers to access for countries with fewer economic resources. Learn how PATH is supporting low- and middle-income country vaccine manufacturers as they work to bring vaccines to the global market.

With 34 team members, 95% of whom are based in the countries where we work, we are actively working on 32 projects and have a network of more than 4,000 users.

The meningococcal meningitis prevention landscape has transformed in the last 15 years with the introduction of affordable, effective vaccines to the African meningitis belt. But we need more to ensure sustainable access.